Humakhag, Ferlyn H.
HRN: 21-27-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/01/2024
03/02/2024
IV
500 Mg
Q8
Abortion Incomplete
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes